Secukinumab psoriatic arthritis future 1

No progression in joint damage in 84% of psoriatic,THU0414 Secukinumab Inhibits Radiographic Progression in,Secukinumab, a human anti-interleukin-17A monoclonal,Novartis AG 2017 Q1 – Results – Earnings Call Slides,Top News From ACR 2014: Slideshow,Psoriatic Arthritis Joint Symptoms – COSENTYX (secukinumab),Ruth Viana | LinkedIn,Sites of hand or wrist involvement and their potential,Sites of hand or wrist involvement and their potential,.

.